Impax Laboratories

Impax Laboratories, Inc. is a technology-based specialty Pharmaceutical company applying its formulation expertize and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products.
Hayward, US
Size (employees)
1,495 (est)+16%
Impax Laboratories was founded in 1999 and is headquartered in Hayward, US

Impax Laboratories Office Locations

Impax Laboratories has offices in Hayward, Philadelphia, Chalfont, Zhunan Township
Hayward, US
Zhunan Township, TW
Chalfont, US
Philadelphia, US

Impax Laboratories Metrics

Impax Laboratories Summary

Market capitalization

$645.7 m

Closing share price

Impax Laboratories's current market capitalization is $645.7 m.

Impax Laboratories Financials

Impax Laboratories's revenue is $511.5 m in FY, 2013 which is a 14.2% decrease from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016


$511.5 m$596 m$860.5 m$824.4 m

Revenue growth, %


Cost of goods sold

$312.2 m$283.4 m$508.1 m

Gross profit

$199.3 m$312.7 m$352.4 m

Operating expense total

$205.7 m$223.8 m$282.8 m


($6.4 m)$88.8 m$69.6 m

Interest expense

($419 k)($43 k)($27.3 m)

Interest income

$1.3 m$1.5 m$1 m

Income tax expense

$45.7 m$33.2 m$20.4 m

Pre tax profit

$146.9 m$90.6 m$59.4 m

Net Income

$101.3 m$57.4 m$39 m($472 m)

Operating cash flow

$42.5 m$30.3 m$125.5 m

Impax Laboratories Market Value History

Impax Laboratories Company Life

You may also be interested in